World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
21116
World Ranking
15293
National Ranking
585

Harry Hollema publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Harry Hollema sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 289 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Harry Hollema D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Harry Hollema sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Harry Hollema is affiliated with the University Medical Center Groningen in the Netherlands. Their research spans medicine with a strong focus on biochemistry, genetics, and molecular biology, reflected by 13 publications in medicine and 11 in biochemistry, genetics, and molecular biology.

The main subfields of Hollema's work include genetics, oncology, immunology, cancer research, and pathology and forensic medicine. They have contributed notably to topics such as BRCA gene mutations in cancer, cancer immunotherapy and biomarkers, immunotherapy and immune responses, cancer genomics and diagnostics, interferon and immune responses, viral infections and vectors, and cancer-related molecular mechanisms research.

Recent papers authored or coauthored by Hollema include:

  • Association of homozygous variants of STING1 with outcome in human cervical cancer (2020), published in Cancer Science
  • Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study (2020), published in Lara D. Veeken
  • Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients (2021), published in OncoImmunology
  • High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors (2023), published in Journal of Clinical Oncology
  • Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome (2020), published in BMC Women s Health

Hollema frequently collaborates with several researchers, including:

  • Marian J.E. Mourits
  • Joost Bart
  • Geertruida H. de Bock
  • Iris A.S. Stroot
  • Marise M. Wagner

Their work is often published in venues such as E-Posters, Cancer Science, Lara D. Veeken, OncoImmunology, and the Journal of Clinical Oncology, with contributions distributed across these platforms.

Best Publications

  • Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

    Liesbeth Bergman;Maureen L R Beelen;Maarten P W Gallee;Harry Hollema

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

    Ninke Leffers;Marloes J. M. Gooden;Renske A. de Jong;Baukje-Nynke Hoogeboom

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

  • In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

    Wouter B. Nagengast;Elisabeth G. de Vries;Geke A. Hospers;Nanno H. Mulder

  • Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

    Ying Wu;Maran J.W. Berends;Rob G.J. Mensink;Claudia Kempinga

  • Molecular and Clinical Characteristics of MSH6 Variants: An Analysis of 25 Index Carriers of a Germline Variant

    Maran J.W. Berends;Ying Wu;Rolf H. Sijmons;Rob G.J. Mensink

  • Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins

    Boudewijn E. C. Plaat;Harry Hollema;Willemina M. Molenaar;Gerben H. Torn Broers

  • Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

    Marc Baay;Wim Quint;J. Koudstaal;H. Hollema

  • Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections

    Sibrand Poppema;Harry Hollema;Lydia Visser;Hans Vos

  • Vulvar carcinoma: The price of less radical surgery

    Joanne A De Hullu;Harry Hollema;Sietske Lolkema;Marike Boezen

  • Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study

    Maaike H Oonk;Bettien M van Hemel;Harry Hollema;Joanne A de Hullu

  • Tamoxifen treatment and gynecologic side effects: a review.

    Marian J.E Mourits;Elisabeth G.E De Vries;Pax H.B Willemse;Klaske A Ten Hoor

  • Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma.

    Gerben Duns;Eva van den Berg;Inge van Duivenbode;Jan Osinga

  • Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.

    Liqiang Qi;Joost Bart;Lu Ping Tan;Inge Platteel

  • Tissue distribution of the death ligand TRAIL and its receptors

    Diana C. Spierings;Elisabeth G. de Vries;Edo Vellenga;Fiona A. van den Heuvel

  • Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Human Ovarian Tumors and Tumor-associated Macrophages

    Alida H. Klimp;Harry Hollema;Claudia Kempinga;Ate G. J. van der Zee

  • Lymphvascular space involvement : an independent prognostic factor in endometrial cancer

    Justine M. Briët;Harry Hollema;Nathalie Reesink;Jan G. Aalders

  • Management of extracolonic tumours in patients with Lynch syndrome

    Jan J Koornstra;Marian J E Mourits;Rolf H Sijmons;Annemarie M Leliveld

  • Risk and Prognosis of Endometrial Cancer After Tamoxifen for Breast Cancer

    L. R. Beelen;Maarten P. W. Gallee;Harry Hollema;Jantien Benraadt

Frequent Co-Authors

Hans W. Nijman
Hans W. Nijman University Medical Center Groningen
Elisabeth G.E. de Vries
Elisabeth G.E. de Vries University Medical Center Groningen
Jan H. Kleibeuker
Jan H. Kleibeuker University Medical Center Groningen
Rolf H. Sijmons
Rolf H. Sijmons University of Groningen
Robert M.W. Hofstra
Robert M.W. Hofstra Erasmus University Rotterdam
Toos Daemen
Toos Daemen University Medical Center Groningen
Charles H.C.M. Buys
Charles H.C.M. Buys University of Groningen
Flora E. van Leeuwen
Flora E. van Leeuwen Antoni van Leeuwenhoek Hospital
Wim Quint
Wim Quint Erasmus University Rotterdam
Ed Schuuring
Ed Schuuring University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but want flexible options, a variety of online healthcare degrees can help you start or advance your career. For those just entering the nursing profession, an lpn accelerated program offers a fast track to becoming a licensed practical nurse, combining speed with accredited training.

Nurses looking to further specialize can explore bsn to np programs online. These programs provide advanced skills and qualifications, often allowing students to balance work and study.

If you’re drawn to the administrative side of healthcare, online healthcare administration programs are designed to develop the management expertise needed in clinics, hospitals, or large health organizations.

For professionals seeking graduate-level advancement without a large financial burden, the cheapest online mha degrees can offer a direct pathway to leadership roles in the industry.

These online pathways make it easier than ever to join or progress in the field of healthcare, regardless of your previous experience or current commitments.

Best Scientists Citing Harry Hollema

Trending Scientists

Recently Published Articles